Methylene Blue in Early Septic Shock

clinical trial

Details

Instance of: clinical trial
Start time: 17 March 2017
End time: September 2020
Country: Mexico
Main subject: septic shock, shock
clinical trial phase: phase II clinical trial, phase III clinical trial
maximum age: 80
minimum age: 18
number of participants: 90
research intervention: methylene blue
research subject recruitment status: recruiting
short name: SHOCKEM-Blue
study type: interventional study
title: Early Use of Methylene Blue in Patients With Septic Shock: a Pilot Randomized Controlled Trial

Nothing in the MetaHistoryBook collection references this item yet.